From Dispensing Someone Else's Brand to Creating Your Own
Recorded sources last checked on October 11, 2026. 9 of 9 recorded claims have no open issue recorded. Source check due April 11, 2027. The page also includes 2 Inventory Ready estimates as of August 4, 2026; estimates are not counted as sourced claims.
By Greg Huang, founder since 2009 in the dietary supplement and nutrition industry
A wellness practitioner who dispenses third-party supplements is operating one business model. A practitioner who creates their own branded supplements is operating a different one. They share a setting (the practice) and a patient base, but the role you play, the contracts you sign, and the cash flows you absorb are not the same.
The short answer
Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.
Two practice models, very different roles
This guide is for the practitioner sitting at the transition. You have been stocking another brand's product for years. Patients trust your recommendation. The question is whether to graduate from dispensing to creating, and what changes when you do.
What changes: your relationship with the manufacturer
When you dispense a third-party brand, you either buy its product wholesale and resell it from your practice, or recommend it through an online dispensing platform that ships to your patients and pays you a margin on their orders. Either way, you do not control the formula. You do not control packaging. You do not control whether the brand changes ingredients or discontinues a SKU.
When you create your own brand, you purchase from the manufacturer, but you are at a different point in their workflow. You are buying production capacity, not finished branded inventory. You provide the formula (private label catalog selection or custom specification) and the label and packaging design. You absorb the inventory until your patients purchase it. You set the retail price.
The trade-off is direct. You take on more capital risk and more operational work. In exchange, you take a larger share of the per-unit margin and you control the product. In a 2021 Nutraceutical Business Review analysis by Bakley Smith of Green Circle Capital Partners, Vern Christensen is quoted on distribution control: “The control of distribution is a major issue that all brands will face. Distribution growth will become more direct-to-channel (DTC) focused and, hopefully, brands will be able to control where products are sold online and get a better ‘prescription’ model.”
What does not change: your relationship with the patient
The supplement is not the asset. The relationship is. Your patients trust your clinical judgment. They buy supplements you recommend because of that trust. The brand on the bottle is downstream of the trust, not the source of it.
This matters when you plan the transition. Patients who already buy a product on your recommendation are the first test of your own version. The harder question is operational: can your practice handle a branded SKU you own, with the inventory, returns, and quality-assurance work that comes with it?
Your patient base does not need you to keep dispensing the brand they currently buy. They need you to keep being right about what they should take.
The business math
Dispensing a third-party brand through an online dispensing platform means no inventory to buy upfront: the platform stocks and ships the product, and pays you a margin on each sale. That margin has a ceiling. On Fullscript, one large dispensing platform, a US practitioner can give patients a discount of up to 35 percent, and giving the full discount leaves the practitioner no profit on the order, so the discount and the margin come out of the same 35 percent.
Creating your own brand changes the margin structure. A private-label SKU at 100 to 500 units MOQ runs $5 to $15 per unit cost of goods (Inventory Ready estimate; it varies with dosage form, ingredient profile, and packaging). Retail at $30 to $50 per unit is typical for practitioner-channel SKUs (Inventory Ready estimate). At $10 cost of goods and a $40 retail price, gross margin is 75 percent per unit, but that figure does not account for the working capital you tie up in unsold inventory.
If you order 500 units at $10 per unit, you have committed $5,000 plus packaging and design costs. If patients buy 50 units a month, part of that inventory sits on your shelves for 10 months before the last unit sells. The per-unit margin is real. The cash flow profile is harder than the third-party dispensing model.
This is why your first SKU under your own brand should be a product the practice already sells consistently from the third-party brand. Its sales give you a starting estimate of demand and inventory turns, which your own version, with its own formula and price, then has to confirm. The transition is a margin-improvement decision, not a market-creation decision.
The regulatory surface that becomes yours
Dispensing a third-party brand puts most regulatory responsibility on that brand. The firm named on its label is the responsible person for serious adverse event reports and must send FDA any such report it receives. FDA must also be notified, by the manufacturer, packer, or distributor, within 30 days of first marketing a product whose label or labeling carries a structure-function claim. The facility that manufactures the product carries its FDA food-facility registration.
Creating your own brand transfers most of that regulatory surface to you. The serious adverse event reporting duty sits with whichever firm is named on the label as manufacturer, packer, or distributor, so if your company is named there, it is yours; check whose name your label carries. A retailer named on the label as distributor may agree that the manufacturer or packer submits those reports, as long as the retailer forwards to it every adverse event reported through the label's contact details. As the brand owner, you make sure that you or your manufacturer or packer sends FDA that 30-day notice for each structure-function claim on your label or in your labeling. Each facility that manufactures, processes, packs, or holds food must be registered with FDA unless it qualifies for one of the exemptions in 21 CFR 1.226, so when a contract manufacturer makes your product, the registration duty is that facility's; a site you operate that packs or holds the product may need its own registration unless an exemption applies. You become responsible for any structure-function claim on your label or in your labeling.
This is manageable but not trivial. Understanding the difference between "supports the immune system" (FDA says this phrase on its own is not specific enough to imply disease prevention) and "supports the body's antiviral capabilities" (FDA treats this as a disease claim) is a load-bearing skill for a brand owner, and it was someone else's responsibility before. FDA also judges each statement in the context of the rest of the label and other labeling, so surrounding words and images can still turn it into a disease claim.
For an introduction to the FDA structure-function claim envelope, see the IR structure-function claims guide. For the wider regulatory surface a first-time brand owner inherits, see supplement legal risks.
Timing considerations
The wrong time to create your own brand is when you are testing whether a category sells in your practice. Dispense the third-party version first. Generate 6 to 12 months of data (a window Inventory Ready suggests) on which SKUs your patients actually buy versus what they say they will buy.
The right time to create your own brand is when one or two SKUs from your dispensary turn over consistently and patients ask for refills without prompting. That signal is what custom inventory commitment requires.
You can run both models in parallel during the transition. Keep dispensing third-party brands for SKUs whose sales have not yet shown steady demand, and create your own brand for the one or two whose sales have. Treat those sales as a starting estimate that your own version still has to confirm. As each of your own SKUs proves its demand, more of your revenue can move to your own brand. Third-party dispensing fills the gaps until a practitioner-branded equivalent justifies the inventory commitment.
What this transition does not replace
Creating your own supplement brand does not replace your clinical practice. It does not turn you into a manufacturer (you contract with a manufacturer). It does not turn you into a fulfillment operator if you choose a manufacturer or third-party logistics partner who handles dispensing.
It does add a business owner role to your existing practitioner role. You sign manufacturer contracts. You approve formulas. You manage inventory turns. You make pricing decisions. You face FDA compliance responsibility for your label. The practice still pays the bills. The brand becomes a margin-enhancement layer on top of the practice, not a replacement for it.
Frequently asked questions
Can I sell my own brand without giving up the third-party brands I currently dispense?
Yes. You can run both. The third-party brands fill in categories your own line does not cover yet. Over time, your own SKUs can replace third-party SKUs in categories where demand justifies the inventory commitment.
Do I need to stop dispensing through my current platform if I create my own brand?
Not necessarily. The two channels can run side by side. Before you launch, read your platform agreement for any limit on selling your own products alongside its catalog.
What changes about my insurance when I become a brand owner?
A professional liability policy is written for clinical practice; ask your broker whether yours covers products you sell under your own brand. Owning a brand adds product risk: claims arising from the supplement itself, not from your clinical recommendation. Product liability insurance covers that risk. One supplement-specialist broker says it can be bought on its own but is usually bought as part of a commercial general liability policy, and reports premiums starting at $1,500 a year, with $3,000 to $3,500 typical for startup brands under about $2 million in annual sales.
How does my state licensing board view this transition?
Ask your board. Before launch, read your state licensing board's rules on selling products from your practice, including products you own.
What if patients ask why the brand changed?
Be honest. Give your clinical reasons (you created this to control the formula and the quality bar), and tell patients that you own the brand and earn from its sales. Patients come to you for your clinical judgment, so they should know when you have a financial interest in a product you recommend.
See where you stand before you commit
Moving from dispensing to owning a brand is a readiness question as much as a product question. Our free readiness quiz shows which pieces you already have and which need work. Take the readiness quiz →
Greg Huang, founder since 2009 in the dietary supplement and nutrition industry
Founder of Inventory Ready. Previously founded and operated multiple consumer brands in the dietary supplement and nutrition industry since summer 2009.
Stay informed
Regulatory updates, new manufacturer assessments, tool launches, product news and offers.